The PlusOne Program at Northeastern University allows students to accelerate their study by applying graduate credits taken as an undergraduate toward both an undergraduate and a graduate degree.
There are several main reasons why this option might be right for you.
Professionals with graduate level experience are likely to be more competitive upon entering the workforce.
The MS in Biotechnology, a certified Professional Master of Science program, combines advanced technical courses with a significant component of business courses preparing for work in the biotechnology industrial setting. A PlusOne degree program can accelerate receipt of a graduate degree and reduce its cost, since in most cases, a PlusOne degree student can earn a graduate degree with only one additional year of study beyond the Bachelor’s.
To receive information, click here
Admissions Requirements and Deadlines:
- Applicants must already be enrolled in a Northeastern College of Science undergraduate biology or biochemistry program
- Application (online submission only), personal goal statement, resume, pre-requisite form
- Official transcripts of all undergraduate study (Northeastern transcripts must be requested by the applicant). Applicants who have been accepted and enrolled must submit official non-US institution transcripts to Educational Credential Evaluators (ECE) or Center for Educational Documentation or World Education Services (WES) for credentialing. Transcripts not in English must be credentialed at the time of application.
- Three letters of recommendation
- The application deadline for Fall 2015 is August 1, 2015 and for Spring 2016 is December 1, 2015. Applicants must apply in their 5th or 6th undergraduate semester.
MS in Biotechnology, Biopharmaceutical Analytical Sciences Track
The biopharmaceutical analytical sciences concentration focuses on structures and activities of biological molecules and their variants formed during the production of biopharmaceuticals. Students learn the diversity of molecular forms derived from the biological products through various biological and chemical mechanisms, and the impact of these structural changes on the safety and efficacy of these biopharmaceuticals. The students learn the science and practice applied in the biotechnology industry to analyze and characterize these molecular forms. This is accomplished through both lecture courses of the analytical sciences and project-driven laboratory experience that utilizes analytical techniques such as mass spectroscopy and molecular separations.
MS in Biotechnology, Process Sciences Track
The process development concentration focuses on the production of drug substance of biopharmaceuticals from cell culture process to purification of the biologic molecules. The students learn the principles of development and implementation of biological manufacturing processes through the integration of concepts and fundamentals of engineering and life sciences. The concentration addresses biochemical engineering, mammalian cell culture process development and protein purification. The learning of the students is reinforced by both lecture courses and project-driven laboratory experience that provides hands-on learning of cell culture and protein separation.
MS in Biotechnology, Pharmaceutical Technologies Track
The pharmaceutical technology concentration focuses on the conversion of purified proteins to biopharmaceutical drug products that are compatible for clinical use. This concentration addresses the design of the product formulation, the development and implementation of the drug product manufacturing processes. Students learn the sciences of the interactions of the biologic molecules in the process conditions and the relevant process technology, such as aseptic operations and freeze-drying, needed for drug product manufacturing. This is accomplished through both lecture courses and project-driven laboratory experience that provides hands-on learning of formulation design and drug product process development.
Industrial Advisory Board representatives from:
Biogen Idec, Inc.
Cyta Therapuetics, Inc.
EMD Serono Research Institute
GlycoFi, Merck & Co., Inc.
Novartis Institutes of Biomedical Research, Inc.
Takeda Pharmaceuticals International Co.